• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. A randomized, controlled trial comparing Ⅳ iron sucrose to oral iron in anemic patients with nondial

A randomized, controlled trial comparing Ⅳ iron sucrose to oral iron in anemic patients with nondial

来源 :2013年中国肾性贫血治疗专家共识研讨会 | 被引量 : 0次 | 上传用户：riyueshen1969
【摘 要】
：
A randomized, controlled trial comparing Ⅳ iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD.Background.Although iron deficiency frequently complicates anemia in patients wit
【作 者】
：
DAVID B.VAN WYCK MICHAEL ROPPOLO CARLOS O.MARTINEZ RICHARD M.MAZEY STEPHEN MCMURRAY 
【机 构】
：
University of Arizona College of Medicine, Tucson, Arizona
【出 处】
：
2013年中国肾性贫血治疗专家共识研讨会
【发表日期】
：
2012年12期
【关键词】
：
CKD anemia iron iron deficiency iron sucrose 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
A randomized, controlled trial comparing Ⅳ iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD.Background.Although iron deficiency frequently complicates anemia in patients with nondialysis-dependent CKD (NDCKD), the comparative treatment value of Ⅳ iron infusion and oral iron supplementation has not been established.
其他文献
Hemoglobin Variability and Mortality in ESRD
Hemoglobin levels vary substantially over time in hemodialysis patients, and this variability may portend poor.outcomes.For a given patient, hemoglobin concentration over time can be described by abso
会议
Hemoglobin Variability in Nondialysis Chronic Kidney Disease: Examining the Association with Mortali
Background and objectives: Anemia and hemoglobin (Hb) variability are associated with mortality in hemodialysis patients who are on erythropoiesis-stimulating agents (ESA).Our aim was to describe the
会议
Hemoglobin Variability Does Not Predict Mortality in European Hemodialysis Patients
Patients with CKD exhibit significant within-patient hemoglobin (Hb) level variability, especially with the use of erythropoiesis stimulating agents (ESAs) and iron.Analyses of dialysis cohorts in the
会议
Hemoglobin Level Variability: Associations with Comorbidity, Intercurrent Events, and Hospitalizatio
National payment policies target a hemoglobin range of 11 to 12.5 g/dl for patients with ESRD.However, clinical complications and provider practices may contribute to wide fluctuations over time.This
会议
Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney dis
Background: Anemia secondary to iron deficiency is common in patients with non-dialysis dependent chronic kidney disease (ND-CKD) but it is unclear if oral supplementation is as effective as intraveno
会议
AnemiaIronChronic kidney disease
Iron Indices in Chronic Kidney Disease in the National Health and Nutritional Examination Survey 198
Background and objectives: Anemia is a common and early complication of nondialysis chronic kidney disease (CKD).One contributing factor is iron deficiency, which may be particularly problematic durin
会议
Can the Response to Iron Therapy Be Predicted in Anemic Nondialysis Patients with Chronic Kidney Dis
Background and objectives: Anemia is iron responsive in 30 to 50% of nondialysis patients with chronic kidney disease (CKD), but the utility of bone marrow iron stores and peripheral iron indices to p
会议
Low hemoglobin density potential marker of iron availability
Introduction: Low hemoglobin density (LHD%) is a new parameter provided by Beckman-Coulter derived from the mean cell hemoglobin concentration, using the mathematical sigmoid transformation LHD% =100
会议
Functional iron deficiencyhypochromic red blood cellslow hemoglobin densityer
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatme
Background.Iron deficiency is a common cause of anaemia and hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) in non-dialysis-dependent chronic kidney disease (ND-CKD) patients.Current in
会议
anaemiaCKDferritinintravenous irontransferrin saturation
Ferric Gluconate Is Highly Efficacious in Anemic Hemodialysis Patients with High Serum Ferritin and
Few data exist to guide treatment of anemic hemodialysis patients with high ferritin and low transferrin saturation (TSAT).The Dialysis Patients Response to Ⅳ Iron with Elevated Ferritin (DRIVE) trial
会议